Free Float 57,97 %
Shares Float 11,23 M
Shares Outstanding 19,37 M
BioPlus Acquisition Corp.
Share · KYG112171171 · BIOS (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BioPlus Acquisition Corp.
No Price
Share Float & Liquidity
Company Profile for BioPlus Acquisition Corp. Share
BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York.
Company Data
Name BioPlus Acquisition Corp.
Company BioPlus Acquisition Corp.
Symbol BIOS
Website
https://bioplusspac.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN KYG112171171
Asset Class Share
Sector Financial Services
Industry Shell Companies
CEO R. Ross Haghighat
Market Capitalization 209 Mio
Country United States of America
Currency USD
Employees -
Address 260 Madison Avenue, 10026 New York City
IPO Date 2022-01-28
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | BIOS |
More Shares
Investors who hold BioPlus Acquisition Corp. also have the following shares in their portfolio:
